GENE TRANSFER INTO HEMATOPOIETIC STEM CELLS
基因转移至造血干细胞
基本信息
- 批准号:6346218
- 负责人:
- 金额:$ 20.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-01 至 2001-08-31
- 项目状态:已结题
- 来源:
- 关键词:Lentivirus Macaca mulatta Retroviridae SCID mouse biotechnology cell population study clinical research disease /disorder model erythropoiesis gene therapy genetic regulatory element globin hematopoietic stem cells hemoglobin F human subject human tissue laboratory mouse messenger RNA polymerase chain reaction recombinant virus sickle cell anemia sickling inhibitor thalassemia transfection /expression vector
项目摘要
This project is focused on the development of effective strategies for correcting the disease phenotype by therapeutic gene transfer into stem cells of mice and humans with sickle cell anemia. Our goals are to identify a vector system that is capable of achieving relatively efficient gene transfer into primitive human hematopoietic cells under conditions which preserve or expand their numbers and repopulating potential. A second goal is to develop a therapeutic expression cassette which can be used to directly increase the amount of gamma mRNA in transduced cells or to activate the endogenous gamma-globin genes through expression of a transcriptional factor, transdominant mutant therefor or antisense sequences targeted toward a relevant mRNA. A third goal is to model gene therapy protocols in mice with sickle cell disease using drug selection to amplify a genetically normal or gene corrected minority population of hematopoietic cells. The research proposed under the first specific aim is designed to test the hypothesis that the intrinsic biological advantages of lentiviral vectors, namely the relative stability of the pre-integration complex and the ability of this nucleoprotein complex do transverse the nuclear membrane, will allow a higher frequency of transduction of primitive human transfer into repopulating cells. Research is also proposed to close the gap in our knowledge regarding the recovery and transducibility of repopulating cells from patients with sickle cell anemia. The second specific aim is organized around the basic hypothesis that retroviral mediated gene transfer into hematopoietic stem cells can be used to achieve a therapeutic level of gamma-globin gene expression in maturing erythroblasts. Two strategies will be pursued concurrently. 1) development of an erythroid specific expression cassette that generates high levels of exogenous gamma-globin mRNA and 2) evaluation of various genetic elements with respect to their capacity to activate the exogenous gamma-globin genes. Research proposed specific aim 3 is designed to use murine models of human hemoglobin disorders, severe beta thalessemia or sickle cell disease, to test the hypothesis that a minority of cells that have been genetically modifier by retroviral mediated gene transfer can be amplified by drug selection using the dihydrofolate reductase selection system leading to cure of the hemoglobin disorder. Experiments are proposed to vigorously test the selection system in the context of competitive repopulation thereby providing useful information for developing gene therapy protocols for patients with sickle cell disease in the future.
该项目的重点是通过治疗性基因转移到患有镰状细胞性贫血的小鼠和人类的干细胞中来纠正疾病表型的有效策略的开发。我们的目标是确定一个载体系统,能够实现相对有效的基因转移到原始的人类造血细胞的条件下,保持或扩大其数量和重新填充的潜力。第二个目标是开发一种治疗性表达盒,其可用于直接增加转导细胞中γ mRNA的量或通过表达转录因子、其反式显性突变体或靶向相关mRNA的反义序列来激活内源性γ-珠蛋白基因。第三个目标是在患有镰状细胞病的小鼠中模拟基因治疗方案,使用药物选择来扩增造血细胞的遗传正常或基因校正的少数群体。在第一个具体目标下提出的研究旨在检验慢病毒载体的内在生物学优势(即整合前复合物的相对稳定性和该核蛋白复合物确实穿过核膜的能力)将允许将原始人转移更高频率地转导到重建细胞中的假设。还建议进行研究以缩小我们在镰状细胞性贫血患者再生细胞的恢复和可转导性方面的知识差距。差距。第二个具体目标是围绕逆转录病毒介导的基因转移到造血干细胞中可用于在成熟成红细胞中实现治疗水平的γ-珠蛋白基因表达的基本假设组织的。将同时采取两项战略。1)产生高水平外源γ-珠蛋白mRNA的红细胞特异性表达盒的开发和2)评价各种遗传元件激活外源γ-珠蛋白基因的能力。研究提出的具体目标3旨在使用人类血红蛋白疾病、重度β地中海贫血或镰状细胞病的小鼠模型,以检验以下假设:通过逆转录病毒介导的基因转移进行遗传修饰的少数细胞可以通过使用二氢叶酸还原酶选择系统进行药物选择而扩增,从而治愈血红蛋白疾病。实验中提出了大力测试的选择系统的竞争性再增殖的背景下,从而提供有用的信息,为镰状细胞病患者的基因治疗方案在未来的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARTHUR W. NIENHUIS其他文献
ARTHUR W. NIENHUIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARTHUR W. NIENHUIS', 18)}}的其他基金
Gene Transfer for Galactosialidosis - Resub
半乳糖唾液酸贮积症的基因转移 - Resub
- 批准号:
8823767 - 财政年份:2013
- 资助金额:
$ 20.21万 - 项目类别:
Gene Transfer for Galactosialidosis - Resub
半乳糖唾液酸贮积症的基因转移 - Resub
- 批准号:
8627165 - 财政年份:2013
- 资助金额:
$ 20.21万 - 项目类别:
Gene Transfer for Galactosialidosis - Resub
半乳糖唾液酸贮积症的基因转移 - Resub
- 批准号:
8499926 - 财政年份:2013
- 资助金额:
$ 20.21万 - 项目类别:
Development of gene therapy for wiskott-aldrich syndrome (WAS)
威斯科特-奥尔德里奇综合征 (WAS) 基因疗法的开发
- 批准号:
7784215 - 财政年份:2010
- 资助金额:
$ 20.21万 - 项目类别:
相似国自然基金
基于多组学技术研究肠道微生物在猕猴(Macaca mulatta)衰老过程中的作用机制
- 批准号:32370450
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
猕猴(Macaca mulatta)衰老过程中凝血功能变化规律及基因表达调控机制研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:
太行山猕猴(Macaca mulatta tcheliensis)雌性的配偶选择
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:
猕猴(Macaca mulatta)亚种及其近缘种比较基因组学研究
- 批准号:31471989
- 批准年份:2014
- 资助金额:85.0 万元
- 项目类别:面上项目
相似海外基金
Effects of losartan on mitochondria and prediabetes in rhesus monkeys (Macaca mulatta)
氯沙坦对恒河猴(Macaca mulatta)线粒体和糖尿病前期的影响
- 批准号:
10084237 - 财政年份:2020
- 资助金额:
$ 20.21万 - 项目类别:
Defining the molecular signature of regeneration using single cell sequencing of Macaca Mulatta dorsal root ganglia neurons
使用猕猴背根神经节神经元的单细胞测序定义再生的分子特征
- 批准号:
338608 - 财政年份:2015
- 资助金额:
$ 20.21万 - 项目类别:
Fellowship Programs
Longitudinal Investigation of Maternal Influences on Infant Outcomes Mediated by Physiological Investment and Behavioral Care during Lactation in Rhesus Macaques (Macaca mulatta)
母体对哺乳期生理投入和行为护理介导的恒河猴(Macaca mulatta)婴儿结局影响的纵向调查
- 批准号:
0921978 - 财政年份:2009
- 资助金额:
$ 20.21万 - 项目类别:
Standard Grant
SYSTEMIC ARTERIOPATHY IN SIV-INFECTED RHESUS MACAQUES (MACACA MULATTA)
感染 SIV 的恒河猴 (MACACA MULATTA) 的系统性动脉病
- 批准号:
7562385 - 财政年份:2007
- 资助金额:
$ 20.21万 - 项目类别:
Evaluation of HIV-1 Vaccine Candidates in Macaca mulatta
HIV-1 候选疫苗在猕猴中的评价
- 批准号:
7166863 - 财政年份:2006
- 资助金额:
$ 20.21万 - 项目类别:
Transmissible Spongiforme Encephalopathy in non-human primate model after intraperitoneal sCJD-, vCJD-, and BSE-inoculation in the rhesus monkey (Macaca mulatta)
恒河猴(Macaca mulatta)腹腔内接种 sCJD、vCJD 和 BSE 后非人类灵长类动物模型中的传染性海绵状脑病
- 批准号:
5442913 - 财政年份:2005
- 资助金额:
$ 20.21万 - 项目类别:
Research Grants
RETINAL AGING IN MACACA MULATTA FROM PUERTO RICO
波多黎各猕猴的视网膜老化
- 批准号:
2706021 - 财政年份:1999
- 资助金额:
$ 20.21万 - 项目类别:
Zur Kooperation und Konkurrenz unter weiblichen Rhesusaffen (Macaca mulatta). Was bedeutet Verwandtschaft für Primaten: Vertrautheit oder gemeinsame Allele?
雌性恒河猴(Macaca mulatta)之间的合作与竞争。
- 批准号:
5186152 - 财政年份:1999
- 资助金额:
$ 20.21万 - 项目类别:
Research Grants
VISUAL SLIDES ON SELF INJURIOUS BEHAVIOR IN RHESUS MONKEYS (MACACA MULATTA)
关于恒河猴(MACACA MULATTA)自残行为的视觉幻灯片
- 批准号:
6277743 - 财政年份:1998
- 资助金额:
$ 20.21万 - 项目类别:
PANCREATIC ENDOCRINE NEOPLASM IN RHESUS MACAQUE (MACACA MULATTA)
恒河猴(MACACA MULATTA)胰腺内分泌肿瘤
- 批准号:
6247525 - 财政年份:1997
- 资助金额:
$ 20.21万 - 项目类别: